Osobine

Reference

1. ^U.S. Patent 3.254.083
2. ^Poeldinger W (јануар 1962). „[Therapeutic experiences with thiopropazate and with a combination of thiopropazate and chlorphencyclan (Vesitan) in psychiatry]”.Praxis (на језику: немачки).51: 73—8.PMID 14487367. CS1 одржавање: Формат датума (веза)
3. ^Ghose, A.K.; Viswanadhan V.N. & Wendoloski, J.J. (1998).„Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”.J. Phys. Chem. A.102: 3762—3772.doi:10.1021/jp980230o. 
4. ^Tetko IV, Tanchuk VY, Kasheva TN, Villa AE (2001).„Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”.Chem Inf. Comput. Sci.41: 1488—1493.PMID 11749573.doi:10.1021/ci000392t. 
5. ^Ertl P.; Rohde B.; Selzer P. (2000).„Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”.J. Med. Chem.43: 3714—3717.PMID 11020286.doi:10.1021/jm000942e. 

Literatura

• Hardman JG, Limbird LE, Gilman AG (2001).Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill.ISBN 0071354697.doi:10.1036/0071422803. 
• Thomas L. Lemke; David A. Williams, ур. (2007).Foye's Principles of Medicinal Chemistry (6. изд.). Baltimore: Lippincott Willams & Wilkins.ISBN 0781768799. 

Spoljašnje veze